Muna Qayed

Summary

Affiliation: Children's Healthcare of Atlanta
Country: USA

Publications

  1. doi request reprint Rifaximin for preventing acute graft-versus-host disease: impact on plasma markers of inflammation and T-cell activation
    Muna Qayed
    AFLAC Cancer and Blood Disorders Center, Atlanta, GA 30322, USA
    J Pediatr Hematol Oncol 35:e149-52. 2013
  2. doi request reprint Is the updated Schwartz formula appropriate for assessing renal function prior to hematopoietic stem cell transplantation?
    Muna Qayed
    Aflac Cancer Center and Blood Disorders Service, Emory University and Children s Healthcare of Atlanta, Atlanta, Georgia, USA
    Pediatr Blood Cancer 55:199-201. 2010
  3. doi request reprint Gemcitabine and docetaxel (GEMDOX) for the treatment of relapsed and refractory pediatric sarcomas
    Louis Rapkin
    Division of Pediatric Hematology Oncology, AFLAC Cancer Center, Children s Healthcare of Atlanta, Emory University, Atlanta, Georgia, USA
    Pediatr Blood Cancer 59:854-8. 2012
  4. doi request reprint Ewing sarcoma with 7;22 translocation: three new cases and clinicopathological characterization
    Sarah Catherine Shulman
    Department of Pathology, Children s Healthcare of Atlanta, Atlanta, Georgia 30322, USA
    Fetal Pediatr Pathol 31:341-8. 2012
  5. doi request reprint Tandem stem cell rescue as consolidation therapy for high-risk neuroblastoma
    Muna Qayed
    AFLAC Cancer Center, Division of Pediatric Hematology Oncology, Emory University and Children s Healthcare of Atlanta, GA 30322, USA
    Pediatr Blood Cancer 58:448-52. 2012

Collaborators

Detail Information

Publications5

  1. doi request reprint Rifaximin for preventing acute graft-versus-host disease: impact on plasma markers of inflammation and T-cell activation
    Muna Qayed
    AFLAC Cancer and Blood Disorders Center, Atlanta, GA 30322, USA
    J Pediatr Hematol Oncol 35:e149-52. 2013
    ..This suggests that rifaximin may abrogate bacterial translocation and resultant inflammation, but in alternative donor transplants this does not prevent downstream activation of donor T cells...
  2. doi request reprint Is the updated Schwartz formula appropriate for assessing renal function prior to hematopoietic stem cell transplantation?
    Muna Qayed
    Aflac Cancer Center and Blood Disorders Service, Emory University and Children s Healthcare of Atlanta, Atlanta, Georgia, USA
    Pediatr Blood Cancer 55:199-201. 2010
    ..Agreement between both formulas and DTPA-Tc-(99m) was poor, although the updated formula performed marginally better. The Schwartz formulas do not appear to be accurate enough to be used for pre-transplant kidney function evaluation...
  3. doi request reprint Gemcitabine and docetaxel (GEMDOX) for the treatment of relapsed and refractory pediatric sarcomas
    Louis Rapkin
    Division of Pediatric Hematology Oncology, AFLAC Cancer Center, Children s Healthcare of Atlanta, Emory University, Atlanta, Georgia, USA
    Pediatr Blood Cancer 59:854-8. 2012
    ..Patients with relapsed pediatric sarcomas have a poor outcome and are in need of novel effective therapies...
  4. doi request reprint Ewing sarcoma with 7;22 translocation: three new cases and clinicopathological characterization
    Sarah Catherine Shulman
    Department of Pathology, Children s Healthcare of Atlanta, Atlanta, Georgia 30322, USA
    Fetal Pediatr Pathol 31:341-8. 2012
    ..In comparison to conventional ES with t(11;22) (q24;q12) (EWS-FLI1), the t(7;22) ES variant has a higher propensity for females and children in a younger age group and it occurs more commonly in extraosseous locations...
  5. doi request reprint Tandem stem cell rescue as consolidation therapy for high-risk neuroblastoma
    Muna Qayed
    AFLAC Cancer Center, Division of Pediatric Hematology Oncology, Emory University and Children s Healthcare of Atlanta, GA 30322, USA
    Pediatr Blood Cancer 58:448-52. 2012
    ..We retrospectively describe our institutional experience in using HDC/SCR for patients with high-risk NB, focusing on outcome and acute toxicities...